DMSO Efficacy in IC/PBS Patients During and After Treatment
NCT01074567 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2011-04-05
Summary
The purpose of this study is to examine the efficacy of dimethylsulphoxide (DMSO) cocktail in patients with interstitial cystitis during the treatment period (12 weeks) and after it (at 6 weeks, 3, 6 and 12 month).
Conditions
- Cystitis, Interstitial
Interventions
- DRUG
-
DMSO cocktail
intra-vesical: DMSO 50% in 50 cc water for injection 10 cc heparin 5000 IU hydrocortisone 100 mg bupivacaine 0.125%
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Principal Investigators
-
Kobi Stav, MD · Assaf-Harofe MC
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2011-12-31
- Completion
- 2012-12-31
Countries
- Israel
More Related Trials
-
PK and Safety of SI-722 in IC/BPS
NCT04208087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
NCT01990898 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
NCT00275379 ·Status: WITHDRAWN ·Phase: NA
-
The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
NCT01813565 ·Status: TERMINATED ·Phase: NA
-
An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis
NCT00739739 ·Status: COMPLETED ·Phase: PHASE2
-
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
NCT05811377 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
NCT00919113 ·Status: COMPLETED ·Phase: PHASE2
-
Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome
NCT05699551 ·Status: WITHDRAWN ·Phase: NA
-
Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis
NCT04821882 ·Status: COMPLETED ·Phase: NA
-
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
NCT04610359 ·Status: UNKNOWN ·Phase: PHASE1
-
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
NCT00527917 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
NCT02331472 ·Status: COMPLETED
-
Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
NCT01559961 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
NCT04734106 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
NCT04095572 ·Status: RECRUITING ·Phase: PHASE4
-
Intravesical Liposomes for Ulcerative Cystitis
NCT01083979 ·Status: COMPLETED ·Phase: NA
-
Platelet Enriched Plasma for Treatment of Interstitial Cystitis
NCT04118946 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC
NCT05223244 ·Status: COMPLETED ·Phase: PHASE4
-
Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome
NCT06285214 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
NCT01985880 ·Status: COMPLETED
-
Diclofenac Suppository to Control Pain During Flexible Cystoscopy
NCT01812928 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
NCT02366676 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis
NCT00823030 ·Status: WITHDRAWN ·Phase: NA
-
Sacral Neuromodulation in Patients With IC
NCT00590473 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
NCT02411110 ·Status: COMPLETED ·Phase: PHASE2